Groups

Research Focus

Former Employee. MSK At 53 Street; Per Diem, Nurse Practitioner

Recent additions – View all

1. A randomized, controlled, open-label, phase 2 study of cemiplimab ± RP1 in patients with advanced cutaneous squamous cell carcinoma (CERPASS)

   Meeting Abstract

   Haydon, A. M.; Khushalani, N. I.; Robert, C.; Brungs, D.; Collichio, F. A.; Colevas, A. D.; Lim, A. M. L.; Kudchadkar, R. R.; Chai-Ho, W.; Daniels, G. A.; more...
   Journal of Clinical Oncology (2022)

   Fulltext@MSK | Save